Article Information
History
- July 15, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Hiba Dagher1,
- Anne-Marie Chaftari1,*,
- Ishwaria M. Subbiah2,
- Alexandre E. Malek1,
- Ying Jiang1,
- Peter Lamie3,
- Bruno Granwehr1,
- Teny John1,
- Eduardo Yepez1,
- Jovan Borjan4,
- Cielito Reyes5,
- Mary Flores5,
- Fareed Khawaja1,
- Mala Pande6,
- Noman Ali3,
- Raniv Rojo7,
- Daniel D. Karp8,
- Ray Hachem1 and
- Issam Raad1
- 1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 2Integrative Medicine Program, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 3Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 4Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 5Emergency Medicine-Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 6Gastroenterology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 7Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 8Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- ↵*Corresponding author:
Anne-Marie Chaftari, Department of Infectious Diseases, Infection Control and Employee Health, Unit 1460, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. Tel: 713-792-3491, Email: achaftari{at}mdanderson.org